Your browser doesn't support javascript.
loading
Anti-angiogenic effects of Qingdu granule on breast cancer through inhibiting NFAT signaling pathway.
Zhao, Xin; Liu, Jinyu; Feng, Lili; Ge, Shasha; Yang, Shijun; Chen, Chen; Li, Xiaoya; Peng, Lin; Mu, Yuxue; Wang, Yueqi; Gu, Daozhao; Guo, Yi; Lin, Geng; Deng, Bo; Cheng, Zhiqiang; Cai, Dayong.
Afiliação
  • Zhao X; Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100193, China; Department of Oncology of Integrative Chinese and Western Medicine, China-Japan Friendship Hospital, Beijing 100029, China. Electronic address: xzhao@implad.ac.cn.
  • Liu J; Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100193, China. Electronic address: ljinyu001@163.com.
  • Feng L; School of Pre-Clinical Medicine, Beijing University of Chinese Medicine, Beijing 100029, China. Electronic address: fll005@163.com.
  • Ge S; Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100193, China. Electronic address: geshasha789@163.com.
  • Yang S; Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100193, China. Electronic address: sjyang@implad.ac.cn.
  • Chen C; Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100193, China. Electronic address: cchen@implad.ac.cn.
  • Li X; Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100193, China. Electronic address: 15110007797@yeah.net.
  • Peng L; Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100193, China; School of Pre-Clinical Medicine, Beijing University of Chinese Medicine, Beijing 100029, China. Electronic address: 657334926@qq.com.
  • Mu Y; Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100193, China; School of Pre-Clinical Medicine, Beijing University of Chinese Medicine, Beijing 100029, China. Electronic address: 771250027@qq.com.
  • Wang Y; School of Pre-Clinical Medicine, Beijing University of Chinese Medicine, Beijing 100029, China. Electronic address: yueqiwng@gmail.com.
  • Gu D; Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100193, China. Electronic address: galenia@163.com.
  • Guo Y; Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100193, China. Electronic address: yguo@implad.ac.cn.
  • Lin G; Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100193, China. Electronic address: glin@implad.ac.cn.
  • Deng B; Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100193, China; Department of Oncology of Integrative Chinese and Western Medicine, China-Japan Friendship Hospital, Beijing 100029, China. Electronic address: elisedeng@hotmail.com.
  • Cheng Z; Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100193, China; Department of Oncology of Integrative Chinese and Western Medicine, China-Japan Friendship Hospital, Beijing 100029, China. Electronic address: zhiqiangcheng@163.com.
  • Cai D; Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100193, China; Department of Oncology of Integrative Chinese and Western Medicine, China-Japan Friendship Hospital, Beijing 100029, China. Electronic address: dycai@implad.ac.cn.
J Ethnopharmacol ; 222: 261-269, 2018 Aug 10.
Article em En | MEDLINE | ID: mdl-29337215
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Medicamentos de Ervas Chinesas / Inibidores da Angiogênese / Neoplasias Mamárias Experimentais Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: J Ethnopharmacol Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Medicamentos de Ervas Chinesas / Inibidores da Angiogênese / Neoplasias Mamárias Experimentais Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: J Ethnopharmacol Ano de publicação: 2018 Tipo de documento: Article